Every Possible Advantage®
Paragonix Organ Preservation and Transport Devices offer every possible advantage on the transplant journey.
Every Possible Advantage®
Paragonix Organ Preservation and Transport Devices offer every possible advantage on the transplant journey.
Comparison of Traditional Ice Storage vs Paragonix Organ Transport Solutions1
Stable Temperature
Superior Clinical Results
Real-Time Data
Team Communication
Dedicated Support Team
ICE STORAGE
Stable Temperature
Superior Clinical Results
Real-Time Data
Team Communication
Dedicated Support Team
Precision Cooling System
Paragonix SherpaCool™ Ribbons’ proprietary phase-change technology prevents exposure to excessive temperature reduction. The lightweight shipper system is validated for a consistent thermal environment for over 40 hours. This combination provides a stable temperature environment for the donor organ across the entire transplant journey.
Caution: Federal (US) law restricts this device to sale by or in the order of a licensed health care practitioner. Please refer to Instructions for Use for full prescribing information. Cleared indication for Paragonix SherpaPak is for 4-hour use. Cleared indication for Paragonix LUNGguard is for 8-hour use. Patents issued and pending. See Indications For Use for more information.
GUARDIAN-HEART Clinical Results
First Report of the GUARDIAN Registry: An International Consortium Examining the Effect of Controlled Hypothermic Preservation in Heart Transplantation. Impact Multiple Stages of The Transplant Process.
+8.7%
1-year Survival1
P = 0.03
-72%
Severe PGD1
P = 0.005
-39%
All Post-Tx MCS1
P = 0.03
Comparison of Paragonix SherpaPak to Ice Storage, Paragonix data on file. GUARDIAN is a registered clinical study (NCT04141605) funded and administered by Paragonix Technologies. At the time of this analysis, GUARDIAN contained data from 17 sites on 849 patients (384 ice transports and 465 Paragonix SherpaPak CTS transports). The data from the registry is descriptive, not statistically powered, and not pre-specified. The information should be interpreted accordingly. In this analysis, US adult cohorts were matched using statistical propensity matching to create cohorts of equal baseline characteristics (149 ice transports and 149 Paragonix SherpPak CTS transports) with a matching propensity score allowable difference of 0.025.
Paragonix App
ORGAN STATUS
LOCATION
CASE STATUS
COMMUNICATION
Paragonix Support Team
Paragonix Technologies has an experienced global clinical support team ready to answer any type of question you could have about Paragonix organ transport products. Our team offers real-time support and indivualized training for anyone involved in the organ transport process.
What are Cardiothoracic Surgeons Saying?
“I felt like our recipient got a Superman heart”
– Dr. Robert Dowling, Cardiothoracic Transplant Surgeon, Hershey Medical Center (Hershey, PA)2
1. D’Alessandro et al., The Journal of Heart and Lung Transplantation 2021, Volume 40, Issue 4, Supplement , S127, April 01, 2021
2. Hershey Medical Center first in PA to use new device to transport donor hearts.
https://news.psu.edu/story/661773/2021/06/17/hershey-medical-center-first-pa-use-new-device-transport-donor-hearts
